AMPE Ampio Pharmaceuticals
- 0.252
- -0.078-23.64%
Ampio Pharmaceuticals News
Ampio Pharmaceuticals Received Audit Opinion With Going Concern Explanation
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed in its Annual Report on...
Ampio Pharmaceuticals Q4 EPS $(2.48) Up From $(3.60) YoY
Ampio Pharmaceuticals (AMEX:AMPE) reported quarterly losses of $(2.48) per share. This is a 31.11 percent increase over losses of $(3.60) per share from the same period last year.
Top Midday Decliners
Cardlytics (CDLX) shares slumped after the company proposed on Tuesday a $150 million offering of convertible senior notes due 2029 while saying it expects to grant initial purchasers an option to buy
VERI, CHEK and CZOO Among Mid-day Movers
NYSE American New 52-Week Highs And Lows
New Highs 4 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Imperial Oil IMO 69.46 21,217 Sk
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings
US stock futures were trending higher in Tuesday's premarket session ahead of durable goods and house price data, alongside the latest consumer confidence gauge, due later in the morning. The Dow Jone
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Durable Goods, Consumer Confidence Data
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.5% higher in Tuesday's premarket activity ahead of the US durable g
Top Premarket Decliners
NeuBase Therapeutics (NBSE) stock fell 58% in recent Tuesday premarket activity, extending Monday's decline. AppTech Payments (APCX) shares tumbled 40% a day after saying it planned to sell its common
Ampio Pharmaceuticals Takes Voluntary Decision to Delist From NYSE American; Shares Plunge Premarket
Ampio Pharmaceuticals (AMPE) said late on Monday that its board voluntarily decided to delist its common stock from the NYSE American. The company said the board based its decision on factors such as
Ampio Shares Fall 22% as Co. Plans to Voluntarily Delist From NYSE American
By Stephen Nakrosis Shares of Ampio Pharmaceuticals were touching 52-week lows in late trading Monday, following the company's plan to voluntarily delist shares from the NYSE American Exchange. Ampi
Ampio Announces Voluntary Delisting and SEC Deregistration
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that its Board of Directors determined to voluntarily...
Earnings Week Ahead: Walgreens Boots Alliance, Carnival, GameStop and More
Ampio Pharmaceuticals, Ironwood, Incannex Among Healthcare Movers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersEnveric Biosciences (NASDAQ:ENVB) stock rose 162.3% to $2.18 during Thursday's pre-market session. The company's market cap stands at $5.9 million. Societal CDMO (NASDAQ:SCTL) shares moved upwa
Ampio Pharmaceuticals Ends Equity Distribution and Alters Strategy
Ampio Pharmaceuticals Up 26% on Securities-Sale Updates
By Josh Beckerman Ampio Pharmaceuticals were recently up 26%, to $2.32, after updates regarding sales of securities. The company said it would terminate an at-the-marketing offering agreement. It al
Ampio Pharmaceuticals Files FormRW To Terminate That Certain At The Marketing Offering Agreement, Dated September 18, 2023
- SEC FilingOn February 26, 2024, Ampio Pharmaceuticals, Inc. (the "Company") provided a notice to H.C. Wainwright & Co., LLC to terminate that certain At The Marketing Offering Agreement, dated Septe
Ampio Pharmaceuticals Withdraws Filing for Offering of Stock and Warrants
Ampio Pharmaceuticals Withdraws Filing for Offering of Stock and Warrants
Ampio Pharmaceuticals Announces Nonclinical Study Success
Ampiolans To Take Immediate Actions To Preserve Its Cash In Order To Be Able To Adequately Fund Any Option Identified By Board
The Company's management and the Board are currently assessing both internal and external options.
Analysis
Price Target
No Data
